title: MGMT promoter methylation status in anaplastic meningiomas.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Brokinkel
authors.forename: Bernhard R
authors.initials: BR
authors.lastname: Fischer
authors.forename: Susanne
authors.initials: S
authors.lastname: Peetz-Dienhart
authors.forename: Heinrich
authors.initials: H
authors.lastname: Ebel
authors.forename: Abolghassem
authors.initials: A
authors.lastname: Sepehrnia
authors.forename: Burckhard
authors.initials: B
authors.lastname: Rama
authors.forename: Friedrich K
authors.initials: FK
authors.lastname: Albert
authors.forename: Walter
authors.initials: W
authors.lastname: Stummer
authors.forename: Werner
authors.initials: W
authors.lastname: Paulus
authors.forename: Martin
authors.initials: M
authors.lastname: Hasselblatt
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000378:metabolism*; D008579:Meningioma / Q000188:drug therapy / Q000378:metabolism*; D008875:Middle Aged; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000378:metabolism*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D019853:O(6)-Methylguanine-DNA Methyltransferase
references.citation: Cancer Res. 2008 Jul 15;68(14):5706-15
references.pmid: 18632623
references.citation: Cancer Genet Cytogenet. 2008 Nov;187(1):25-7
references.pmid: 18992637
references.citation: Neurology. 2004 Apr 13;62(7):1210-2
references.pmid: 15079029
references.citation: J Neurooncol. 2009 Jan;91(2):151-5
references.pmid: 18795231
references.citation: Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50
references.pmid: 16145534
references.citation: Acta Neuropathol. 2004 Nov;108(5):413-21
references.pmid: 15365725
references.citation: J Clin Oncol. 2007 Sep 10;25(26):4127-36
references.pmid: 17827463
references.citation: Nat Rev Neurol. 2010 Jan;6(1):39-51
references.pmid: 19997073